Close Message
None
  1. Lumen Biomedical sells core product to Volcano to generate much needed cash

    Explore Article MedCity News (Feb 11 2010) Cardiology , Acquisition

    PLYMOUTH, Minnesota– Lumen Biomedical Inc. has sold one of its two clot removing devices to boost its balance sheet as the company struggles to stay afloat in a tough economy. Volcano Corporation, a San Diego-based medical device manufacturer, purchased Lumen’s Xtract catheter for an undisclosed sum. The company had been Xtract’s exclusive global distributor since May 2009. In an interview, Lumen CEO Steven Healy said the company wanted to move out of manufacturing and focus on product development. “We saw [the Volcano deal] as a way in a tough financial market to raise much needed funds,” Healy said. “Lots of ...

    Comment on Article Mentions:   Volcano

  2. Volcano Has AAA Week: Accused, Approved and Acquired

    Explore Article ptca.org (Feb 10 2010) Cardiology , Acquisition , Other Business News

    Volcano Has AAA Week: Accused, Approved and Acquired Volcano Corporation (Nasdaq: VOLC) has had a pretty interesting week. Last Thursday was the low point: a 13 person jury in Massachusetts Superior Court found Volcano and its subsidiary Axsun liable for a number of contractual breaches against LightLab Imaging, Inc. These all grew out of Volcano's purchase of Axsun, a company that had exclusive contracts with LightLab, Volcano's main competitor in the Optical Coherence Tomography (OCT) field. The court has set March 22 as the start of the damages assessment phase. But today, Volcano made two more positive announcements. The FDA has approved Volcano's latest IVUS catheter, the Eagle ...

    Comment on Article Mentions:   LightLab Imaging   Volcano   Axsun Technologies

  3. Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract Thrombus Aspiration Catheter

    Explore Article Yahoo! Finance (Feb 9 2010) Cardiology , Acquisition , Other Business News

    Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract Thrombus Aspiration Catheter SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical. Volcano became the exclusive global distributor of the Xtract™ catheter in May 2009. This acquisition reinforces Volcano's dedication to build a strategic portfolio of diagnostic and therapeutic tools to help patients with coronary artery disease at all levels of complexity, including acute myocardial infarction (AMI) or heart attacks.

    Comment on Article Mentions:   Volcano

  4. Canon set to purchase Polish Optopol after lengthy talks

    Explore Article Warsaw Business Journal (Dec 23 2009) Acquisition

    Japanese optical instrument producer Canon has agreed to spend a sum of zł.248 million to take over a 90 percent stake in publicly-listed Optopol Technology, a company which produces equipment for the ophthalmology sector. The two enterprises have managed to come to an agreement after almost a year of negotiations. The Bogdani family, the main shareholders in the domestic firm, will receive zł.19 for each share they sell, and they will sell almost 7.7 million shares while the remaining shareholders will sell shares at zł.20 per piece. Although Canon wanted to acquire a 100 percent stake in the firm, CEO ...

    Comment on Article Mentions:   Optopol Technology   Canon Medical Systems

  5. Canon launches $94 million bid for Polish Optopol

    Explore Article iii.co.uk (Dec 22 2009) Ophthalmology , Acquisition

    Canon launches $94 million bid for Polish Optopol WARSAW, Dec 22 (Reuters) - Japanese company Canon has offered to buy Optopol, a Polish maker of equipment for eye surgery diagnostics, for 276 million zlotys ($94 million), a brokerage running the transaction said on Tuesday. The bid by the Japanese camera and office equipment maker values Optopol at 20 zlotys per share, although the Bogdani family has agreed to sell its 54 percent stake stake ...

    Comment on Article Mentions:   Optopol Technology   Canon Medical Systems

  6. Canon Bids $85M for Optopol, Polish Eye Diagnostic Device Maker

    Explore Article Bloomberg.com (Dec 22 2009) Ophthalmology , Acquisition

    Canon Bids $85M for Optopol, Polish Eye Diagnostic Device Maker Dec. 22 (Bloomberg) -- Canon Inc. bid 248 million zloty ($85 million) to take over Optopol SA, a Polish maker of diagnostic equipment for eye doctors, as it seeks to take the lead in the sector. Canon offered to pay 19 zloty a share to members of the Bogdani family, and 20 zloty to other holders of the Zawiercie, Poland-based company’s stock, Canon said in a statement on its Web site. Optopol surged 22 percent to 19.62 zloty in Warsaw trading at 10:27 a.m. The benchmark WIG20 Index rose 1.2 percent. Canon is betting the acquisition will help reach its ...

    Comment on Article Mentions:   Optopol Technology   Canon Medical Systems

  7. Volcano Posts Q3 Loss; Backs FY09 View; Makes $11M milestone payment to Cardiospectra

    Explore Article RTTNews (Nov 5 2009) Cardiology , Acquisition , Other Business News

    Volcano Corporation (VOLC: News ) reported a third-quarter GAAP net loss of $4.0 million or $0.08 per share, compared with a GAAP net income of $744 thousand or $0.01 per share in the year-ago quarter. Non-GAAP net income, which excludes stock-based compensation expense of $2.6 million and commissions of $1.4 million, was $7 thousand or $0.00 per share. This compares with the year-ago non-GAAP net income of $3.3 million or $0.06 per share, excluding stock-based compensation expense of $2.5 million. On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.12 per share. Analysts' ...

    Comment on Article Mentions:   Volcano   Axsun Technologies   CardioSpectra

  8. Opko Health’s New Acquisition (AMEX:OPK)

    Explore Article istockanalyst.com (Oct 5 2009) Acquisition , Other Business News

    Formerly known as Ophthalmic Technologies Inc. Opko Health has recently agreed to acquire Chilean pharmaceutical company named Pharma Genexx for around US$ 16 million in cash. One of the reasons why this Florida-based pharma giant is taking up Chilean pharmaceutical is to enter the emerging markets in the future. The Miami-based Opko Health is a specialty healthcare company that is currently involved in the discovery, development and commercialization of pharmaceutical products, vaccines and diagnostic technologies. However, with this acquisition Opko Health is looking to expand into new areas like oncology and neurological disorders. Opko Health CEO and Chairman Philip Frost ...

    Comment on Article Mentions:   OTI Ophthalmic Technologies Inc.   UT Southwestern Medical Center

  9. Optopol Reportedly Close To Being Acquired

    Explore Article investing.businessweek.com (Sep 18 2009) Ophthalmology , Acquisition

    It was reported that Optopol Technology SA will be acquired by a trade investor. A source told "Parkiet" that the transaction would not take place this month, but once it has been signed, the sale process would accelerate. Adam Bogdani, the company's president, did not confirm or deny the information. It is expected Optopol will be acquired by Canon Inc.

    Comment on Article Mentions:   Optopol Technology   Canon Medical Systems

  10. Thorlabs Acquires Covega

    Explore Article Photonics.com (Mar 29 2009) Acquisition

    NEWTON, N.J., and FREMONT, Calif., March 24, 2009 – Photonics equipment maker Thorlabs Inc. has acquired Covega Corp., a provider of optoelectronic components and modules, for an undisclosed amount. The announcement was made jointly by Newton, N.J.-based Thorlabs and integrated photonics company Gemfire Corp. of Fremont, Calif., former owner of Covega

    Comment on Article Mentions:   Thorlabs   Covega   Alex E. Cable

  11. Thorlabs acquires Covega from Gemfire

    Explore Article semiconductor-today.com (Mar 26 2009) Acquisition

    Photonics component maker Thorlabs Inc of Newton, NJ has acquired optoelectronic component and subsystem maker Covega Corp of Jessup, MD from Gemfire Corp. Founded in 1999 as Codeon Corp before changing its name in 2003, Covega is a vertically integrated manufacturer of proprietary gain chips, semiconductor optical amplifiers (SOAs) and other indium phosphide (InP) based components and modules as well as lithium niobate (LiNbO3) technology

    Comment on Article Mentions:   Thorlabs   Covega   Alex E. Cable

  12. Volcano Announces Closing of Axsun Technologies Acquisition

    Explore Article news.prnewswire.com (Jan 7 2009) Acquisition

    SAN DIEGO, Jan. 7 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it has closed its previously announced acquisition of Axsun Technologies, Inc. Axsun is a leading developer and manufacturer of lasers and optical engines used in medical Optical Coherence Tomography (OCT) imaging systems and advanced photonic components and subsy

    Comment on Article Mentions:   Axsun Technologies   Volcano

  13. Volcano Corporation Schedules Conference Call, Webcast to Discuss Axsun Transaction

    Explore Article news.prnewswire.com (Jan 5 2009) Cardiology , Acquisition

    SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, will conduct a conference call and webcast Tuesday, January 6, to discuss its acquisition of Axsun Technologies, Inc., that was announced on December 23, 2008. The teleconference call and webcast will begin at 1 p.m., Eastern Standard Time (10 a.m., Pacific Standard Time), and ca

    Comment on Article Mentions:   Axsun Technologies   Volcano

  14. Medical imaging company acquires Axsun Technologies for its OCT expertise

    Explore Article Laser Focus World (Dec 30 2008) Cardiology , Acquisition , Tunable Sources

    December 30, 2008--Volcano Corporation (San Diego, CA), developer of products for the diagnosis and treatment of coronary and peripheral artery disease, entered into a definitive agreement to acquire Axsun Technologies (Billerica, MA), a privately held company that develops lasers and optical engines used in optical coherence tomography (OCT) imaging systems and photonic components and subsystems used in other industrial applications.

    Comment on Article Mentions:   Axsun Technologies   Dale Flanders   Scott Huennekens

  15. Volcano Announces Acquisition of Axsun Technologies, Inc. for $21.5M

    Explore Article news.prnewswire.com (Dec 23 2008) Cardiology , Acquisition , Tunable Sources

    Volcano Announces Acquisition of Axsun Technologies, Inc.  for $21.5M Volcano Corporation, a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it has entered into a definitive agreement to acquire Axsun Technologies, Inc., a privately-held company that is a leading developer and manufacturer of lasers and optical engines used in medical Optical Coherence Tomography (OCT) imaging systems and advanced photonic components and subsystems used in other industrial applications.

    Comment on Article Mentions:   Axsun Technologies   Scott Huennekens   Volcano

1-15 of 35 // 1 2 3 »
HomeAll ArticlesProfilesQuotesComments Login Register Powered by HiveFire